Summary:
A nationwide genomic and wearable tracking study led by Kansas State University reveals that daily physical activity significantly attenuates the impact of high genetic susceptibility to major depressive disorder. Utilizing multimodal data from the NIH’s All of Us Research Program, combining genetic profiles, electronic health records, and longitudinal Fitbit metrics, researchers found that higher daily step counts and minutes of moderate-to-vigorous physical activity directly weaken the relationship between polygenic vulnerability and clinical symptom severity in adults.
Key Facts:
- Buffering Genetic Risk: Wearable activity data showed that higher levels of daily movement significantly weaken the statistical link between high genetic predisposition and the severity of depressive symptoms.
- Objective Tracking via All of Us: Rather than relying on self-reported exercise, the study leveraged real-world, longitudinal objective data from Fitbit devices alongside electronic health records and genome-wide sequencing across diverse American adults.
- Spectrum of Severity: Moving beyond binary “yes/no” diagnostic labels, the researchers evaluated granular symptom severity, showing that moderate-to-vigorous activity helps keep subclinical and moderate depressive burdens from escalating.
Source: Kansas State University
Major depressive disorder remains one of the leading causes of disability worldwide, contributing to profound personal, social, and economic burdens. While large-scale genome-wide association studies have firmly established that depression possesses a complex, polygenic architecture driven by thousands of small-effect DNA variants, having a high genetic predisposition does not guarantee a clinical diagnosis.
Understanding which lifestyle factors can effectively buffer or modify this inherent biological vulnerability is a paramount goal of precision psychiatry.
Now, a multi-institutional study led by researchers at Kansas State University, in collaboration with the University of Texas at San Antonio, the University of Rhode Island, and Vanderbilt Health, provides objective evidence that regular physical activity directly weakens the expressive weight of genetic susceptibility to depression.
Publishing in the journal Nature Mental Health, the team harnessed rich longitudinal datasets from the National Institutes of Health’s All of Us Research Program to evaluate how wearable-measured movement interacts with polygenic risk.
Beyond Binary Diagnoses: Real-World Wearable Metrics
A critical limitation in historical psychiatric research has been the reliance on binary classifications—treating depression merely as present or absent—and subjective, self-reported activity surveys that are prone to recall bias.
To overcome these barriers, the research team analyzed comprehensive electronic health records, genomic data, survey responses, and continuous, objective movement metrics gathered from participants’ personal Fitbit devices.
“Depression is one of the leading causes of disability worldwide, so understanding how we might reduce its burden is important,” said lead investigator Denver Brown, PhD, assistant professor in the School of Health Sciences in K-State’s College of Health and Human Sciences. “As we move toward more personalized medicine, understanding a patient’s genetic risk could help inform conversations about lifestyle, including the potential role of physical activity in helping prevent depression or manage its symptoms.”
The investigators evaluated two primary dimensions: formal clinical diagnoses and the spectrum of symptom severity.
“If we’re looking at depression as just a ‘yes or no’ for diagnosis, we’re missing a lot of the variability that comes with a diagnosis,” Brown explained. “Someone may have some symptoms, but not a formal diagnosis. Some might have moderate symptoms, and others experience substantial symptoms.”
Daily Steps and Moderate-to-Vigorous Activity as Genetic Buffers
When assessing common wearable activity benchmarks, specifically daily step counts and total minutes spent in moderate-to-vigorous physical activity (MVPA), the data demonstrated a consistent, protective interaction.
Among adults carrying high polygenic risk scores for major depression, those who consistently maintained higher levels of daily movement exhibited markedly lower symptom severity than their sedentary genetic peers. In essence, regular physical activity altered the phenotypic expression of their DNA, dampening the expected biological burden of inherited vulnerability.
The physiological mechanisms underlying this buffering effect are multifaceted: aerobic movement stimulates neurogenesis in the hippocampus via brain-derived neurotrophic factor (BDNF), downregulates systemic neuroinflammation, and recalibrates hypothalamic-pituitary-adrenal (HPA) axis stress reactivity—pathways frequently dysregulated in individuals with high genetic depression liability.
Toward Tailored, Precision Lifestyle Prescriptions
While the present investigation centered on adults within the All of Us cohort, Brown’s broader research program explores movement behaviors across critical neurodevelopmental inflection points, particularly in adolescents and emerging adults.
“Our research is important, particularly for adolescents and emerging adults, because these life stages coincide with the peak onset of anxiety and depression, and they also coincide with a substantial drop-off in physical activity engagement,” Brown said.
By integrating wearable telemetry with genomics, the findings pave the way for clinicians to draft individualized lifestyle interventions tailored to a patient’s biological profile, prescribing specific daily step thresholds or activity durations to mitigate familial mental health risks.
“With health, there is not a one-size-fits-all approach,” Brown concluded. “By drawing on the wealth of data available from programs like All of Us, we can better understand who may be most vulnerable to chronic health conditions and mental disorders, and inform lifestyle recommendations tailored to their needs. We’re really making strides toward a more personalized approach to health, and this study is a step in that direction.”
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this genetics and depression Research:
- Media Contact: Rafael Garcia
- Source: Kansas State University
- Image Credit: Image credited to Neuroscience News
- Original Research is Open Access: Nature Mental Health (Oct 2, 2026). “Associations and interactions between genetic vulnerability and physical activity with MDD in the All of Us Research Program.” Authors: Qiliang He, Jennifer Zhang, Christopher G. Beevers & Denver M. Y. Brown.
- DOI: 10.1038/s41593-026-02490-y
Abstract
Associations and interactions between genetic vulnerability and physical activity with MDD in the All of Us Research Program
Both genetic liability and physical activity (PA) are well-established contributors to major depressive disorder (MDD), yet large-scale studies integrating device-assessed PA with genomic risk remain limited, and prior gene–environment research has focused almost exclusively on MDD onset rather than symptom severity.
We analyzed 23,517 participants from the All of Us Research Program (mean age, ~56 years; range, 18–92 years; 67.2% female) with whole-genome sequencing and long-term Fitbit-derived PA data (mean wear time of 582 days). PA was operationalized using daily minutes of moderate-to-vigorous PA and steps, and MDD was defined using a dual-source phenotype combining electronic health records and self-reported lifetime diagnosis.
Here we examined both MDD diagnosis and electronic health record-derived symptom severity using regression models testing main and interaction effects of polygenic risk scores (PRSs) and PA, adjusting for demographic covariates.
Across all PA metrics, a higher PRS was robustly associated with increased likelihood of MDD diagnosis, whereas higher PA was associated with lower risk; however, no significant PRS × PA interactions were observed for MDD onset.
By contrast, for symptom severity, both PRS and PA showed significant main effects, and consistent negative interactions emerged across all PA operationalizations and different severity definitions, indicating that higher PA attenuated the association between genetic risk and depressive symptom burden. These interaction patterns were robust across different model specifications.
Together, these findings suggest that genetic and behavioral factors contribute largely independently to MDD onset but interact in shaping symptom expression, highlighting PA as a potential modifier of genetic vulnerability in depression and a potential target for precision mental health interventions.
